Skip to main content
PRCT logo

PROCEPT BioRobotics Corporation

PRCTNASDAQHealthcareMedical Devices

$19.83Today:- (-)1Y −42.14%

As of Oct 26, 2026 close

Market cap
$1.12B
P/E (TTM)
-
Forward P/E
-
Dividend yield
-
52-week range
$16.67$38.11
Volume (live)
-
Avg. volume (3M)
1.31M

PROCEPT BioRobotics (PRCT) Income Statement

PROCEPT BioRobotics reported revenue of $308.05M in fiscal 2025 (fiscal year ended Dec 31, 2025), up 37.2% from $224.50M a year earlier. PROCEPT BioRobotics posted a net loss of $95.57M, compared with a net loss of $91.41M a year earlier. Gross margin was 63.7% and operating margin -33.7%. In the most recent quarter, Q2 fiscal 2026 (ended Jun 30, 2026), revenue was $94.50M, up 19.3% from the same quarter a year earlier.

PROCEPT BioRobotics Income Statement Analysis

Values in millions USD

Scroll to see more
PROCEPT BioRobotics Corporation income statement - Annual data in millions USD
BreakdownFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019
Period endingDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019
Revenue & Gross Profit
Revenue308.05224.50136.1975.0134.477.726.17
Cost of Revenue111.8387.4065.1437.9318.618.978.05
Gross Profit196.23137.1071.0537.0915.87-1.26-1.89
Operating Expenses
Research & Development71.2862.3048.4528.9818.9916.2813.15
Selling, General & Administrative228.81171.42131.7788.8351.0430.2728.52
Operating Expenses300.09233.71180.22117.8170.0346.5541.67
Operating Income-103.86-96.61-109.17-80.72-54.16-47.80-43.55
Other Income/Expense
Interest Income12.0610.907.352.010.080.181.15
Interest Expense3.594.18-4.00-5.185.81-5.260.72
Other Income/Expense8.485.203.35-6.43-5.69-0.141.58
Income
Income Before Tax-95.38-91.41-105.82-87.15-59.85-53.02-41.98
Income Tax Expense0.190.000.080.000.000.000.00
Net Income-95.57-91.41-105.90-87.15-59.85-53.02-41.98
Net Income - Continuous Operations-95.57-91.41-105.90-87.15-59.85-53.02-41.98
Net Income - Discontinued Operations-------
EBITDA-97.47-82.00-105.36-77.88-50.72-44.94-39.76
EBIT-103.86-96.61-109.17-80.72-54.16-47.80-
Depreciation & Amortization6.395.233.812.843.322.861.49
Earnings Per Share
Basic EPS-2.00-2.00-2.00-2.00-1.00-14.00-1.00
Diluted EPS-2.00-2.00-2.00-2.00-1.00-14.00-1.00
Basic Shares Outstanding55.5452.1347.2644.4043.703.6633.59
Diluted Shares Outstanding55.5452.1347.2644.4043.703.6633.59

Source: Company financial statements from annual and quarterly filings. Data as of Jun 30, 2026. Data sources and methodology

Frequently Asked Questions About PROCEPT BioRobotics Financial Statements

What was PROCEPT BioRobotics's revenue in fiscal 2025?

PROCEPT BioRobotics reported revenue of $308.05M in fiscal 2025 (fiscal year ended Dec 31, 2025). That was up 37.2% from $224.50M a year earlier.

Is PROCEPT BioRobotics profitable?

No. PROCEPT BioRobotics reported a net loss of $95.57M in fiscal 2025. In fiscal 2024 it lost $91.41M.

What is PROCEPT BioRobotics's operating margin?

PROCEPT BioRobotics's operating income was −$103.86M on revenue of $308.05M in fiscal 2025, an operating margin of -33.7%, compared with -43.0% a year earlier.

What is net profit margin?

Net profit margin is net income divided by revenue. It shows how much of each dollar of sales a company keeps as profit after all costs, interest and taxes. Full definition